Nanomedicine, Volume IIA: Biocompatibility

© 2003 Robert A. Freitas Jr. All Rights Reserved.

Robert A. Freitas Jr., Nanomedicine, Volume IIA: Biocompatibility, Landes Bioscience, Georgetown, TX, 2003


References 6000-6099

6000. S.U.S. Choi, in D.A. Siginer, H.P. Wang, eds., Developments and Applications of Non-Newtonian Flows, The American Society of Mechanical Engineers, New York, FED Vol. 231/MD-66 (1995):99-105.

6001. J.A. Eastman, S.U.S. Choi, S. Li, L.J. Thompson, S. Lee, “Enhanced thermal conductivity through the development of nanofluids,” in S. Komarnenl, J.C. Parker, H.J. Wollenberger, eds., Nanophase and Nanocomposite Materials II, Materials Research Society, Pittsburgh, PA, Vol. 457 (1997):3-11.

6002. S. Lee, S.U.S. Choi, S. Li, J.A. Eastman, “Measuring thermal conductivity of fluids containing oxide nanoparticles,” ASME J. Heat Transfer 121(1999):280-289.

6003. Jeffrey A. Eastman, Stephen U.S. Choi, Shaoping Li, “Development of energy-efficient nanofluids for heat transfer applications,” Argonne National Laboratory;; “Technology Tour: More about Argonne’s stable, highly conductive nanofluids,” Technology Transfer at Argonne;

6004. J.A. Eastman, S.U.S. Choi, S. Li, W. Yu, L.J. Thompson, “Anomalously increased effective thermal conductivities of ethylene glycol-based nanofluids containing copper nanoparticles,” Appl. Phys. Lett. 78(5 February 2001):718-720.

6005. H. Masuda, A. Ebata, K. Teramae, and N. Hishinuma, “Alteration of thermal conductivity and viscosity of liquid by dispersing ultra-fine particles (dispersion of Al2O3, SiO2, and TiO2 ultrafine particles,” Netsu Bussei (Japan) 4(1990):227-233.

6006. Lorenz Ratke, “Physical properties of aerogels,” 15 November 1999;; Annemarie Meike, “Aerogel for Thermal Insulation,” Lawrence Livermore National Laboratory, 4 October 2000;

6007. M.O. Coppens, G.F. Froment, “Diffusion and reaction in a fractal catalyst pore. III. Application to the simulation of vinyl acetate production from ethylene,” Chem. Eng. Sci. 49(1994):4897-4907.

6008. G.C. Glatzmaier, W.F. Ramirez, “Use of volume averaging for the modeling of thermal properties of porous materials,” Chem. Eng. Sci. 43(1988):3157-3169.

6009. R. Olives, S. Mauran, “A highly conductive porous medium for solid-gas reactions: Effect of the dispersed phase on the thermal tortuosity,” Transport Porous Media 43(2001):377-394;

6010. N. Epstein, “On tortuosity and the tortuosity factor in flow and diffusion through porous media,” Chem. Eng. Sci. 44(1989):777-779.

6011. M. Sahimi, G.R. Gavalas, T.T. Tsotsis, “Statistical and continuum models of fluid-solid reactions in porous media,” Chem. Eng. Sci. 45(1990):1443-1505.

6012. T. Elias-Kohav, M. Sheintuch, D. Avnir, “Steady-state diffusion and reactions in catalytic fractal porous media,” Chem. Eng. Sci. 46(1991):2787-2798.

6013. M. Puncochar, J. Drahos, “The tortuosity concept in fixed and fluidized bed,” Chem. Eng. Sci. 48(1993):2173-2175.

6014. S.W. Wheatcraft, S.W. Tyler, “An explanation of scale-dependent dispersivity in heterogeneous aquifers using concepts of fractal geometry,” Water Resources Research 24(1988):566-578.

6015. Mary J. Cloninger, “Biological applications of dendrimers,” Curr. Opin. Chem. Biol. 6(December 2002):742-748.

6016. Reuven Agami, “RNAi and related mechanisms and their potential use for therapy,” Curr. Opin. Chem. Biol. 6(December 2002):829-834.

6017. P.S. Christopher, David W. Oxtoby, “Density functional model of surfactant mesostructures,” J. Chem. Phys. 117(2002):9502-9509.

6018. Paul Wentworth Jr., Jonathan E. McDunn, Anita D. Wentworth, Cindy Takeuchi, Jorge Nieva, Teresa Jones, Cristina Bautista, Julie M. Ruedi, Abel Gutierrez, Kim D. Janda, Bernard M. Babior, Albert Eschenmoser, Richard A. Lerner, “Evidence for antibody-catalyzed ozone formation in bacterial killing and inflammation science,” Science 298(13 December 2002):2195-2199;; Jean Marx, “Antibodies kill by producing ozone,” Science 298(15 November 2002):1319;

6019. P. Aich, R.J.S. Skinner, S.D. Wettig, R.P. Steer, J.S. Lee, “Long range molecular wire behaviour in a metal complex of DNA,” J. Biomolecular Struct. Dynamics 20(2002):93-98; D.O. Wood, M.J. Dinsmore, G.A. Bare, J.S. Lee, “M-DNA is stablilized by G-C tracts or by the incorporation of 5-fluorouracil,” Nucleic Acids Res. 30(2002):2244-2250;; S.L. Labiuk, L.T.J. Delbaere, J.S. Lee, “Gamma and ultaviolet radiation cause DNA crosslinking in the presence of metal ions at high pH,” Photochem. Photobiol. 73(2001):22-29; A. Rakitin, P. Aich, C. Papadopoulos, Y. Kobzar, A.S. Vedeneev, J.S. Lee, J.M. Xu, “Metallic conduction through engineered DNA: DNA nanoelectronic building blocks,” Phys. Rev. Lett. 86(2001):3670-3673; P. Aich, S.L. Labiuk, L.W. Tari, L.J.T. Delbaere, W.J. Roesler, K.J. Falk, R.P. Steer, J.S. Lee, “M-DNA: a complex between divalent metal ions and DNA which behaves as a molecular wire,” J. Mol. Biol. 294(1999):477-485; J.S. Lee, L.J.P. Latimer, R.S. Reid, “A cooperative conformational change in duplex DNA induced by Zn2+ and other divalent metal ions,” Biochem. Cell. Biol. 71(1993):162-168.

6020. C.A. Parish, M. Hashimoto, K. Nakanishi, J. Dillon, J. Sparrow, “Isolation and one-step preparation of A2E and iso-A2E, fluorophores from human retinal pigment epithelium,” Proc. Natl. Acad. Sci. (USA) 95(8 December 1998):14609-14613;

6021. M. Suter, C. Reme, C. Grimm, A. Wenzel, M. Jaattela, P. Esser, N. Kociok, M. Leist, C. Richter, “Age-related macular degeneration. The lipofusion component N-retinyl-N-retinylidene ethanolamine detaches proapoptotic proteins from mitochondria and induces apoptosis in mammalian retinal pigment epithelial cells,” J. Biol. Chem. 275(15 December 2000):39625-39630;

6022. S. Ben-Shabat, C.A. Parish, M. Hashimoto, J. Liu, K. Nakanishi, J.R. Sparrow, “Fluorescent pigments of the retinal pigment epithelium and age-related macular degeneration,” Bioorg. Med. Chem. Lett. 11(18 June 2001):1533-1540.

6023. H. Shaban, P. Gazzotti, C. Richter, “Cytochrome c oxidase inhibition by N-retinyl-N-retinylidene ethanolamine, a compound suspected to cause age-related macula degeneration,” Arch. Biochem. Biophys. 394(1 October 2001):111-116.

6024. S.C. Finnemann, L.W. Leung, E. Rodriguez-Boulan, “The lipofuscin component A2E selectively inhibits phagolysosomal degradation of photoreceptor phospholipid by the retinal pigment epithelium,” Proc. Natl. Acad. Sci. (USA) 99(19 March 2002):3842-3847;

6025. H. Shaban, C. Borras, J. Vina, C. Richter, “Phosphatidylglycerol potently protects human retinal pigment epithelial cells against apoptosis induced by A2E, a compound suspected to cause age-related macula degeneration,” Exp. Eye Res. 75(July 2002):99-108.

6026. S. De, T.P. Sakmar, “Interaction of A2E with model membranes. Implications to the pathogenesis of age-related macular degeneration,” J. Gen. Physiol. 120(August 2002):147-157.

6027. Benoit Dubertret, Paris Skourides, David J. Norris, Vincent Noireaux, Ali H. Brivanlou, Albert Libchaber, “In vivo imaging of quantum dots encapsulated in phospholipid micelles,” Science 298(29 Nolvember 2002):1759-1762;

6028. Ian Wilmut; from a presentation at the “Mammalian Cloning: Implications for Science and Society” Conference, 26-27 June 1997, Arlington, Virginia.

6029. J.C. Kagan, C.R. Roy, “Legionella phagosomes intercept vesicular traffic from endoplasmic reticulum exit sites,” Nat. Cell Biol. 4(December 2002):945-954; H. Nagai, J.C. Kagan, X. Zhu, R.A. Kahn, C.R. Roy, “A bacterial guanine nucleotide exchange factor activates ARF on Legionella phagosomes,” Science 295(25 January 2002):679-682;

6030. David F. Williams, ed., Systemic Aspects of Biocompatiblity, Vols. 1 & 2, C.R.C. Press International, 1981.

6031. David F. Williams, ed., Biocompatibility of Clinical Implant Materials, CRC Series in Biocompatibility, CRC Press, 1982.

6032. Dennis C. Smith, Biocompatibility of Dental Materials, CRC Press, 1982.

6033. H.F. Hildebrand, ed., Biocompatibility of Co-Cr-Ni Alloys, NATA ASI Series A, Life Sciences, Volume 158, Plenum Publishing Corp., New York, 1989.

6034. Dennis C. Smith, David F. Williams, Biocompatibility of Prosthodontic Materials, CRC Press, 1982.

6035. David F. Williams, Biocompatibility of Orthopedic Implants, CRC Press, 1982.

6036. C.A. Baldamus, W. Schoeppe, K.M. Koch, eds., Biocompatibility in Hemodialysis, S. Karger Publishing, 1983.

6037. David F. Williams, ed., Biocompatibility of Tissue Analogs, CRC Series in Biocompatibility, CRC Press, 1985.

6038. David F. Williams, ed., Techniques of Biocompatibility Testing, CRC Series in Biocompatibility, CRC Press, 1986.

6039. Frederick Sylver, Charles J. Doillon, Biocompatibility: Interactions of Biological and Implantable Materials: Polymers, VCH Publishing, 1989.

6040. E. Piskin, ed., Biologically Modified Polymeric Biomaterial Surfaces, Elsevier Applied Science, 1992.

6041. Wilfried Lemm, ed., The Reference Materials of the European Communities: Results of Hemocompatibility Tests, Kluwer Academic Publishers, 1992.

6042. P.J. Doherty, R.L. Williams, D.F. Williams, A.J.C. Lee, eds., Biomaterial-Tissue Interfaces. Advances in Biomaterials, Vol. 10, Elsevier, Amsterdam, 1992.

6043. Y.F. Missirlis, J.L. Wautier, eds., The Role of Platelets in Blood-Biomaterial Interactions, Kluwer Academic Publishers, 1993.

6044. Steve K. Martinez, Materials Testing and Biocompatibility: Index of New Information and Medical Research Bible, ABBE Publishers Association, Washington, D.C., 1994.

6045. Paul Kovacs, Naim S. Istephanous, eds., Proceedings of the Symposium on Compatibility of Biomedical Implants, Proceedings Series Volume 94-15, Electrochemical Society, 1994.

6046. Shayne C. Gad, Safety Evaluation of Medical Devices, Second Edition, Marcel Dekker, 2002.

6047. Kai-Uwe Lewandrowski, Donald Wise, Debra Trantolo, Joseph D. Gresser, Michael J. Yaszemski, David E. Altobelli, eds., Tissue Engineering and Biodegradable Equivalents: Scientific and Clinical Applications, Marcel Dekker, 2002.

6048. Kay C. Dee, David A. Puleo, Rena Bizios, An Introduction to Tissue-Biomaterial Interactions, Wiley-Liss, 2002.

6049. K.R. Williams, A. Toni, J. Middleton, G. Pallotti, eds., Interfaces in Medicine and Mechanics – 2, Elsevier Applied Science, 1991.

6050. Garth W. Hastings, Cardiovascular Biomaterials, Springer Verlag, 1991.

6051. Kenneth R. St. John, ed., Particulate Debris from Medical Implants: Mechanisms of Formation and Biological Consequences, ASTM Special Technical Publication No 1144, American Society for Testing, 1992.

6052. S. Dawids, ed., Test Procedures for the Blood Compatibility of Biomaterials, Kluwer Academic Publishers, 1993.

6053. Donald Maxwell Brunette, P. Tengvall, M. Textor, eds., Titanium in Medicine: Material Science, Surface Science, Engineering, Biological Responses and Medical Applications, Springer Verlag, 2001.

6054. Eugene Khor, Chitin: Fulfilling a Biomaterials Promise, Elsevier Health Sciences, 2001.

6055. T.K. Daly, P.R. Buseck, P. Williams, C.F. Lewis, “Fullerenes from a fulgurite,” Science 259(1993):1599-1601.

6056. F.R. Di Brozolo, Th. E. Bunch, R.H. Fleming, J. Macklin, “Fullerenes in an impact crater on the LDEF spacecraft,” Nature 369(1994):37-40.

6057. D. Heymann, L.P.F. Chibante, P.R. Brooks, W.S. Wolbach, R.E. Smalley, “Fullerenes in the K/T boundary layer,” Science 265(1994):645-647.

6058. G. Parthasarathy, R. Srinivasan, M. Vairamani, K. Ravikumar, A.C. Kunwar, “Occurrence of natural fullerenes in low grade metamorphosed Proterozoic shungite from Karelia, Russia,” Geochim. Cosmochin. Acta 62(1998):3541-3544.

6059. W.L. Suchanek, J.A. Libera, Y. Gogotsi, M. Yoshimura, “Behavior of C-60 under hydrothermal conditions: transformation to amorphous carbon and formation of carbon nanotubes,” J. Solid State Chem. 160(2001):184-188.

6060. Ron Morgan, “The toxicology of carbon nanotubes: What we do not know, and where we’re going from here,” Speaker Presentation from Space Elevator Conference, Seattle, WA, 12-13 August 2002; and

6061. Russell Potter, “Fiber health science,” Speaker Presentation from Space Elevator Conference, Seattle, WA, 12-13 August 2002; and

6062. T.H. Millard, B. Behrendt, S. Launay, K. Futterer, L.M. Machesky, “Identification and characterisation of a novel human isoform of Arp2/3 complex subunit p16-ARC/ARPC5,” Cell Motil. Cytoskeleton 54(January 2003):81-90; Sophie Launay, “Actin, tail me about phagosome motility,”, 10 January 2003;

6063. I.M. Olazabal, E. Caron, R.C. May, K. Schilling, D.A. Knecht, L.M. Machesky, “Rho-kinase and myosin-II control phagocytic cup formation during CR, but not FcgammaR, phagocytosis,” Curr. Biol. 12(20 August 2002):1413-1418.

6064. F. Zhang, F.S. Southwick, D.L. Purich, “Actin-based phagosome motility,” Cell Motil. Cytoskeleton 53(October 2002):81-88.

6065. R.J. Krieser, K. White, “Engulfment mechanism of apoptotic cells,” Curr. Opin. Cell Biol. 14(December 2002):734-738.

6066. J.L. West, N.J. Halas, “Applications of nanotechnology to biotechnology,” Curr. Opin. Biotechnol. 11(April 2000):215-217.

6067. Scott Sershen, Sarah Westcott, N.J. Halas, J.L. West, “Temperature-sensitive polymer-nanoshell composite for photothermally modulated drug delivery,” J. Biomed. Mater. Res. 51(5 September 2000):293-298.

6068. Jennifer L. West et al, “Optically-active nanoparticles for use in therapeutic and diagnostic methods,” United States Patent Application 20020103517, 1 August 2002; Jennifer L. West et al, “Temperature-sensitive polymer/nanoshell composites for photothermally modulated drug delivery,” United States Patent Application 20020169235, 14 November 2002.

6069. S. Abbott, J. Ralston, G. Reynolds, R. Hayes, “Reversible wettability of photoresponsive pyrimidine-coated surfaces,” Langmuir 15(21 December 1999):8923-8928.

6070. K. Ichimura, S.K. Oh, M. Nakagawa, “Light-driven motion of liquids on a photoresponsive surface,” Science 288(2 June 2000):1624-1626;

6071. Anna Iannelli, Jim Merza, Jacek Lipkowski, “Adsorption of pyrazine at the Au(111)/aqueous solution interface,” J. Electroanal. Chem. 376(10 October 1994):49-57.

6072. N.L. Abbott, C.B. Gorman, G.M. Whitesides, “Active control of wetting using applied electrical potentials and self-assembled monolayers,” Langmuir 11(January 1995):16-18.

6073. B.S. Gallardo, V.K. Gupta, F.D. Eagerton, L.I. Jong, V.S. Craig, R.R. Shah, N.L. Abbott, “Electrochemical principles for active control of liquids on submillimeter scales,” Science 283(1 January 1999):57-60;

6074. M. Byloos, H. Al-Maznai, M. Morin, “Phase transitions of alkanethiol self-assembled monolayers at an electrified gold surface,” J. Phys. Chem. B 105(28 June 2001):5900-5905.

6075. Joerg Lahann, Samir Mitragotri, Thanh-Nga Tran, Hiroki Kaido, Jagannathan Sundaram, Insung S. Choi, Saskia Hoffer, Gabor A. Somorjai, Robert Langer, “A reversibly switching surface,” Science 299(17 January 2003):371-374; and See also: Robert F. Service, “Chemists concoct quick-change surface,” Science 299(17 January 2003):321-323.

6076. Elizabeth Thomson, “MIT’s smart surface switches properties reversibly,” January 2003;

6077. L. Livadaru, R.R. Netz, H.J. Kreuzer, “Interacting chain model for poly(ethylene glycol) from first principles – stretching of a single molecule using the transfer matrix approach,” J. Chem. Phys. 118(2003):1404.

6078. H. Wekerle, U.P. Ketelsen, “Thymic nurse cells – Ia-bearing epithelium involved in T-lymphocyte differentiation?” Nature 283(24 January 1980):402-404.

6079. V.N. Viswanadhan, C. Balan, C. Hulme, J.C. Cheetham, Y. Sun, “Knowledge-based approaches in the design and selection of compound libraries for drug discovery,” Curr. Opin. Drug Discov. Devel. 5(May 2002):400-406; D. O’Connor, “Automated sample preparation and LC-MS for high-throughput ADME quantification,” Curr. Opin. Drug Discov. Devel. 5(January 2002):52-58; T.N. Thompson, “Early ADME in support of drug discovery: the role of metabolic stability studies,” Curr. Drug Metab. 1(November 2000):215-241; S. Ekins, C.L. Waller, P.W. Swaan, G. Cruciani, S.A. Wrighton, J.H. Wikel, “Progress in predicting human ADME parameters in silico,” J. Pharmacol. Toxicol. Methods 44(July-August 2000):251-272.

6080. A.R. Shah, N.U. Rehman, N. Shaikh, N. Isber, “External migration of an infected subcutaneous ICD patch through mammary tissue,” J. Cardiovasc. Electrophysiol. 10(December 1999):1690.

6081. Scientific Device laboratory, “India Ink Product No.755,” Material Data Safety Sheet;’s/India%20Ink%20MSDS.html

6082. MSDS Hyper Glossary; “Threshold Limit Value (TLV)”;

6083. MSDS Hyper Glossary; “Permissible Exposure Limit (PEL), Time-Weighted Average (TWA)”;

6084. C. Yongli, Z. Xiufang, G. Yandao, Z. Nanming, Z. Tingying, S. Xinqi, “Conformational changes of fibrinogen adsorption onto hydroxyapatite and titanium oxide nanoparticles,” J. Colloid Interface Sci. 214(1 June 1999):38-45.

6085. J. Huwyler, “Introduction to the blood-brain barrier,” Blood-Brain Barrier homepage, UCLA Department of Medicine, March 1997;

6086. T.S. Reese, M.J. Karnovsky, “Fine structural localization of a blood-brain barrier to exogenous peroxidase,” J. Cell Biol. 34(July 1967):207-217.

6087. C. Zimmer, R. Weissleder, D. O’Connor, L. LaPointe, T.J. Brady, W.S. Enochs, “Cerebral iron oxide distribution: in vivo mapping with MR imaging,” Radiology 196(August 1995):521-527.

6088. L.G. Remsen, C.I. McCormick, S. Roman-Goldstein, G. Nilaver, R. Weissleder, A. Bogdanov, I. Hellstrom, R.A. Kroll, E.A. Neuwelt, “MR of carcinoma-specific monoclonal antibody conjugated to monocrystalline iron oxide nanoparticles: the potential for noninvasive diagnosis,” AJNR Am. J. Neuroradiol. 17(March 1996):411-418;

6089. L.L. Muldoon, G. Nilaver, R.A. Kroll, M.A. Pagel, X.O. Breakefield, E.A. Chiocca, B.L. Davidson, R. Weissleder, E.A. Neuwelt, “Comparison of intracerebral inoculation and osmotic blood-brain barrier disruption for delivery of adenovirus, herpesvirus, and iron oxide particles to normal rat brain,” Am. J. Pathol. 147(December 1995):1840-1851.

6090. W. Hartig, B.R. Paulke, C. Varga, J. Seeger, T. Harkany, J. Kacza, “Electron microscopic analysis of nanoparticles delivering thioflavin-T after intrahippocampal injection in mouse: implications for targeting beta-amyloid in Alzheimer's disease,” Neurosci. Lett. 338(27 February 2003):174-176.

6091. L. Olson, A. Nordberg, H. von Holst, L. Backman, T. Ebendal, I. Alafuzoff, P. Hartvig, A. Herlitz, A. Lilja, “Nerve growth factor affects 11C-nicotine binding, blood flow, EEG, and verbal episodic memory in an Alzheimer patient (case report),” J. Neural Transm. 4(1992):79-95.

6092. J. Kreuter, “Drug targeting with nanoparticles,” Eur. J. Drug Metab. Pharmacokinet. 19(July-September 1994):253-256.

6093. R.N. Alyaudtin, A. Reichel, R. Lobenberg, P. Ramge, J. Kreuter, D.J. Begley, “Interaction of poly(butylcyanoacrylate) nanoparticles with the blood-brain barrier in vivo and in vitro,” J. Drug Target. 9(June 2001):209-221.

6094. P. Ramge, R.E. Unger, J.B. Oltrogge, D. Zenker, D. Begley, J. Kreuter, H. Von Briesen, “Polysorbate-80 coating enhances uptake of polybutylcyanoacrylate (PBCA)-nanoparticles by human and bovine primary brain capillary endothelial cells,” Eur. J. Neurosci. 12(June 2000):1931-1940.

6095. A. Gessner, C. Olbrich, W. Schroder, O. Kayser, R.H. Muller, “The role of plasma proteins in brain targeting: species dependent protein adsorption patterns on brain-specific lipid drug conjugate (LDC) nanoparticles,” Int. J. Pharm. 214(19 February 2001):87-91.

6096. J. Kreuter, D. Shamenkov, V. Petrov, P. Ramge, K. Cychutek, C. Koch-Brandt, R. Alyautdin, “Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier,” J. Drug Target. 10(June 2002):317-325.

6097. J. Kreuter, “Nanoparticulate systems for brain delivery of drugs,” Adv. Drug Deliv. Rev. 47(23 March 2001):65-81.

6098. J. Kreuter, R.N. Alyautdin, D.A. Kharkevich, A.A. Ivanov, “Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles),” Brain Res. 674(13 March 1995):171-174.

6099. U. Schroder, B.A. Sabel, “Nanoparticles, a drug carrier system to pass the blood-brain barrier, permit central analgesic effects of i.v. dalargin injections,” Brain Res. 710(26 February 1996):121-124.


Last updated on 16 April 2004